Dysport abobotulinumtoxinA regulatory update

FDA accepted for review an sBLA from Ipsen for Dysport abobotulinumtoxinA to treat upper limb spasticity in adult patients. The injectable formulation of botulinum neurotoxin type A complex supplied a...